Galectin‐3 and ST2 as predictors of therapeutic success in high‐risk patients undergoing percutaneous mitral valve repair (MitraClip)

BACKGROUND: Percutaneous mitral valve repair (PMVR) is an interventional treatment option in patients with severe mitral regurgitation (MR) and at high risk for open‐heart surgery. Currently, limited information exists about predictors of procedural success after PMVR. Galectin‐3 (Gal‐3) and suppres...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cardiol
Päätekijät: Dörr, Oliver, Walther, Claudia, Liebetrau, Christoph, Keller, Till, Sommer, Thomas, Boeder, Niklas, Bayer, Matthias, Bauer, Pascal, Möllmann, Helge, Gaede, Luise, Troidl, Christian, Voss, Sandra, Bauer, Timm, Hamm, Christian W., Nef, Holger
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wiley Periodicals, Inc. 2018
Aiheet:
Clinical Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489771/
https://ncbi.nlm.nih.gov/pubmed/29896861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22996
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia